Cohort Company News - MedTech Innovator

2Morrow adds chronic pain management to its mobile behavior therapy offerings

DateFeb 22 2018

As opioid abuse continues to make impact in the US, more and more tech-driven answers to the drug crisis are springing up that aim to reduce patients’ reliance on prescription opioids. Just yesterday, behavioral health therapy app maker 2Morrow threw its hat into the ring with the announcement that its services now include a digital chronic pain management program.

FDA clears Access Vascular’s HydroPICC catheter

DateFeb 22 2018

Access Vascular said today that its HydroPICC catheter has won 510(k) clearance from the FDA. The peripherally-inserted central catheter is designed with Access Vascular’s proprietary bulk-hydrophilic material, which the company touted as “the ideal material for long-term implantable vascular access devices.”

SafeHeal Starts First-in-Human and CE-Mark Clinical Study of Endoluminal Bypass Sheath

DateFeb 22 2018

SafeHeal, developer of the Colovac device, has enrolled the first five patients in its CE mark study. The Colovac device is a unique endoluminal bypass sheath placed in the colon following rectal resection, aimed at significantly improving the recovery of patients after colorectal surgery without the need for an ostomy.

PharmaJet, Genexine Partner for DNA Vaccines

DateFeb 21 2018

PharmaJet has entered a global license agreement with Genexine for the development and commercialization of DNA vaccines for human applications using the PharmaJet needle-free injection systems.

Google Developers Launchpad Studio welcomes more machine learning healthcare startups

DateFeb 14 2018

We're excited to announce the three new startups joining Launchpad Studio, our 6-month mentorship program tailored to help applied-machine learning startups build great products using the most advanced tools and technologies available.

Zenflow raises $31m in Series A

DateFeb 07 2018

Urology medical device maker Zenflow said today it closed a $31.4 million Series A round of financing to support the development of minimally invasive devices designed to treat obstructive urinary symptoms related to benign prostatic hyperplasia.

MedAware Systems Launches Comprehensive Apheresis Research Database

DateJan 31 2018

Broomfield, CO, January 31, 2018 --(PR.com)-- MedAware Systems, Inc. announced today it is launching the world’s most comprehensive database of evidence on Apheresis, available through its SOHInfo™ division. Data have been meticulously extracted from over 2,300 clinical trials, cohort studies, registries, reviews and other published works, spanning medical journals worldwide.

Linear Health Sciences Announces Issuance of First US Patent

DateJan 24 2018

Linear Health Sciences today announced that the United States Patent and Trademark Office has issued the company's first patent related to its flagship product, the Orchid Safety Release Valve™, a patient safety device designed to help prevent intravenous (IV) catheter dislodgement. US Patent No. 9,861,805 B2 covers wide-ranging claims behind the tension-activated safety release valve for use in medical access devices such as IV catheters.

Adhesys Medical gets CE mark for its topical skin adhesive for surgical use

DateJan 22 2018

Adhesys Medical, a surgical adhesive company, said it has received a CE mark for its Mar-Cutis Flix topical skin adhesive for surgical use. The adhesive is a polyurethane-based technology the company said is an innovative alternative to traditional wound closing techniques that features bonding strength, fast sealing and high flexibility.

Day Zero Diagnostics: New Diagnostic Rapidly Identifies The Resistance Profile of Bacteria, Enabling Targeted Therapy Sooner

DateJan 17 2018

At the 2017 meeting of AdvaMed, the medical device industry’s advocacy organization, young start-up Day Zero Diagnostics was chosen as this year’s MedTech Innovator Global Competition winner.

Taglich Brothers Initiates Nexeon Medsystems Inc.

DateJan 16 2018

Nexeon MedSystems Inc., headquartered in Dallas, Texas, is a medical device company developing a neurostimulator technology platform for the treatment of disorders through the electrical stimulation of neural tissues. The company’s first application of its Nexeon Neurostimulation System will be for the treatment of chronic medical conditions such as Parkinson’s and associated diseases in Europe.

Accenture HealthTech Innovation Challenge Names Nanowear as Innovation Champion

DateJan 12 2018

More than 700 startups from around the world participated in the Accenture HealthTech Innovation Challenge that culminated on January 8th at the Startup Health Festival in San Francisco—part of the 36th annual J.P. Morgan Healthcare Conference. Startups participating in the Challenge presented innovative technology and business models to help improve the way people access and manage healthcare.

IntuiTap closes $1.6M and forms strategic partnership

DateJan 11 2018

So excited to announce the close of our $1.6M round including investments from @thepinkceiling & @ionispharma! 2018 is off to a great start!

CROWDFUNDING: The 5 most successful crowdfunding campaigns in 2017

DateJan 06 2018

2017 was a banner year for crowdfunding campaigns. Here are five of the most successful crowdfunding campaigns last year that you need to know about.

Nanowear and The Secant Group announce exclusive supply chain partnership for scaled manufacturing of proprietary cloth-based nanosensor technology

DateJan 05 2018

Nanowear, the leader in cloth-based diagnostic monitoring nanosensor technology, today announced that it has entered into an exclusive, worldwide supply-chain partnership agreement with The Secant Group for scaled manufacturing and production of its medical-grade cloth-based nanosensor technology.

Miracor closes $30m Series D

DateJan 04 2018

Miracor Medical Systems said today it closed a $30.2 million (EU €25 million) round of funding as part of Series D financing round with funds slated to support further development and commercialization of its PiCSO impulse system, and announced it is moving its headquarters from Austria to Belgium.

Genomic Expression Receives $4.2M Grant to Validate Its OneRNA™ Liquid-Biopsy Platform in Bladder Cancer

DateJan 03 2018

The OneRNA4Bladder project aims to save lives and halve the cost of care for bladder-cancer treatment. Bladder cancer is the most expensive cancer to treat due to expensive diagnostic procedures and ineffective drugs resulting in a recurrence rate of 70%.

Denver’s Digital Health Boom

DateJan 02 2018

Medical care is no longer confined to the doctor’s office. Or even, sometimes, to an actual doctor. That iPhone in your pocket now has the capability to diagnose your cough, answer insurance questions, and get you pregnant…or at least help the process along.

Cloud-based platform enables use of AI on medical images

DateJan 02 2018

The Food and Drug Administration has approved Arterys’ web-based imaging analytics platform, which marries cloud-based supercomputing and artificial intelligence, for clinical use.

Virtual Reality Makes for Better-Trained Surgeons

DateDec 13 2017

Some medical technologies can require hundreds of uses before a surgeon becomes proficient with them. Typical surgeon training involves working with cadavers, but doing this only allows trainees one, maybe two, sessions' worth of experience.